Legend®
(hyaluronate sodium)
Details
LEGEND Injectable Solution is indicated in the treatment of joint dysfunction of the carpus or fetlock in horses due to non-infectious synovitis associated with equine osteoarthritis. A horse’s joints often need medical support in order to decrease the effects of equine osteoarthritis. Equine osteoarthritis can happen in any age and any discipline due to everyday wear and tear. It is permanent and can lead to early retirement and quality of life issues in horses.
The active ingredient in LEGEND, hyaluronic acid (HA), decreases the presence of inflammatory mediators in the joint, improves synovial fluid, and improves degrees of lameness. LEGEND is available for intravenous (I.V.) or intra-articular (I.A.) injection. LEGEND hyaluronate sodium injectable is sterile, pyrogen-free, and FDA-approved.
Not for use in humans. Keep this and all other drugs out of reach of children. The safety of LEGEND has not been evaluated in breeding stallions or in breeding, pregnant or lactating mares. LEGEND 4 mL and LEGEND Multi-Dose Injectable Solution are administered by intravenous injection only.
Features & Benefits
Features
-
Millions of doses sold, more than 25 years of treatment success, safe and efficacious, proven by multiple studies
-
Reduces production of inflammatory mediators, joint inflammation, and the resulting lameness for at least 45 days when given once a week for three weeks.4
-
FDA approved joint therapy for both I.V. and I.A. administration, so you can choose the treatment to meet your horse’s need
Benefits
-
Safe and efficacious
-
90% of cases treated I.V. judged to have excellent to good overall clinical improvement1
-
96% of horses treated intra-articularly were judged to have excellent to good overall clinical improvement1
-
Provides multi-modal approach against the cycle of inflammation and lameness
-
Stimulates endogenous hyaluronic acid production2
-
Creates a physical barrier to exclude inflammatory mediators3
-
Decreases the presence of inflammatory mediators4
-
Easy to use I.V. administration for when intra-articular administration is not practical or desired
Dosage & Administration
LEGEND can only be used by or on the order of a veterinarian.
LEGEND Multi Dose (20mL) and LEGEND 4mL (40mg) can be injected intravenously only at a dosage of 4mL. Intravenous treatment may be repeated at weekly intervals for a total of 3 treatments. LEGEND 2mL (20mg) can be injected intravenously (at a dosage of 4mL) or intra-articularly in the carpus or fetlock.
Not for use in humans. Keep this and all other drugs out of reach of children.
For more information please read Legend 2mL Product Information, Legend 4mL Product Information, and Legend Multi-dose 20mL Product Information.
Resources
Safety Information
Federal law restricts this drug to use by or on the order of a licensed veterinarian. For use only in horses. Do not use in horses intended for human consumption.
LEGEND 4 mL and LEGEND® Multi-dose 20 mL are approved only for I.V. use. LEGEND 2 mL is approved for I.V. and I.A. use. The intra-articular safety of LEGEND Multi Dose with benzyl alcohol has not been evaluated.
The safety of LEGEND has not been evaluated in breeding stallions or in breeding, pregnant or lactating mares.
The following adverse reactions have been reported following use of LEGEND Injectable Solution: Following intravenous use: occasional depression, lethargy, and fever. Following intra-articular (LEGEND Injectable Solution — 2 mL only) use: lameness, joint effusion, joint or injection site swelling, and joint pain.
Not for use in humans. Keep this and all other drugs out of reach of children. Strict aseptic techniques should be observed when administering by intra-articular injection.
Store at or below 77° F (25° C). Brief excursions to 104° F (40° C) are permitted.
1. LEGEND Product Label
2. Smith MM, Ghosh P. The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int. 1987;7(3):113-222.
3. McIlwraith CW. Traumatic joint disease. Orthopaedic Research Center, Colorado State University website http://csu-cvmbs.colostate.edu/academics/clinsci/equine-orthopaedic-research-center/orthopaedic-topics/Pages/traumatic-joint-disease.aspx#legend. Accessed July 31, 2015.
4. Kawcak CE, Frisbie DD, Trotter GW, et al. Effects of intravenous administration of sodium hyaluronate on carpal joints in exercising horses after arthroscopic surgery and osteochondral fragmentation. Am J Vet Res. 1997;58(10):1132-1140.
LEGEND® is a registered trademark of Boehringer Ingelheim Animal Health USA Inc. ©2021 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved. US-EQU-0115-2021